These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients. Fuster V; Charlton P; Boyd A Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs. Luo Z; Akita GY; Date T; Treleaven C; Vincent KA; Woodcock D; Cheng SH; Gregory RJ; Jiang C Circulation; 2005 Apr; 111(13):1679-84. PubMed ID: 15781730 [TBL] [Abstract][Full Text] [Related]
11. Novel insights into the pathobiology of the vascular access - do they translate into improved care? Diskin CJ Blood Purif; 2010; 29(2):216-29. PubMed ID: 20093830 [TBL] [Abstract][Full Text] [Related]
12. [Prospective monitoring of vascular access in hemodialysis by means of a multidisciplinary team]. Gruss E; Portolés J; Jiménez P; Hernández T; Rueda JA; del Cerro J; Lasala M; Tato A; Gago MC; Martínez S; Velayos P Nefrologia; 2006; 26(6):703-10. PubMed ID: 17227248 [TBL] [Abstract][Full Text] [Related]
13. Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kelly BS; Heffelfinger SC; Whiting JF; Miller MA; Reaves A; Armstrong J; Narayana A; Roy-Chaudhury P Kidney Int; 2002 Dec; 62(6):2272-80. PubMed ID: 12427156 [TBL] [Abstract][Full Text] [Related]
14. Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Roy-Chaudhury P; Kelly BS; Zhang J; Narayana A; Desai P; Melham M; Duncan H; Heffelfinger SC Blood Purif; 2003; 21(1):99-110. PubMed ID: 12596755 [TBL] [Abstract][Full Text] [Related]
15. Endothelial progenitor cells, neointimal hyperplasia, and hemodialysis vascular access dysfunction: novel therapies for a recalcitrant clinical problem. Roy-Chaudhury P Circulation; 2005 Jul; 112(1):3-5. PubMed ID: 15998692 [No Abstract] [Full Text] [Related]
16. Interventional nephrology in Puerto Rico. Leon FT; Bermudez CR; Hernandez V; Silva J; Delpin ES Semin Dial; 2006; 19(2):176-9. PubMed ID: 16551299 [TBL] [Abstract][Full Text] [Related]
17. Is there a role for Chlamydia pneumoniae in hemodialysis vascular access thrombosis? Zydlewski AW; Stothard DR; Van Der Pol B; Jones RB; Filo RS; Hasbargen JA Am J Kidney Dis; 2000 Dec; 36(6):1122-5. PubMed ID: 11096035 [TBL] [Abstract][Full Text] [Related]
18. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Lee T; Roy-Chaudhury P Adv Chronic Kidney Dis; 2009 Sep; 16(5):329-38. PubMed ID: 19695501 [TBL] [Abstract][Full Text] [Related]
19. Development of a local perivascular paclitaxel delivery system for hemodialysis vascular access dysfunction: polymer preparation and in vitro activity. Melhem M; Kelly B; Zhang J; Kasting G; Li J; Davis H; Heffelfinger S; Desai P; Roy-Chaudhury P Blood Purif; 2006; 24(3):289-98. PubMed ID: 16465049 [TBL] [Abstract][Full Text] [Related]
20. Surgical bypass of symptomatic central venous obstruction for arteriovenous fistula salvage in hemodialysis patients. Suliman A; Greenberg JI; Angle N Ann Vasc Surg; 2008 Mar; 22(2):203-9. PubMed ID: 18346573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]